While two studies failed to demonstrate any prognostic relevance [3, 30], a recent study demonstrated a worse outcome for the small fraction of 7% of grade 3 oligodendrogliomas with homozygous CDKN2A deletions [4]. The gene discussed is CDKN2A; the disease is oligodendroglioma.